CALC: CalciMedica, Inc. Stock

by  •  • Comments Off on CALC: CalciMedica, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.26
Enterprise Value ($M) 20.10
Book Value ($M) 9.03
Book Value / Share 0.67
Price / Book 3.24
NCAV ($M) 8.50
NCAV / Share 0.63
Price / NCAV 3.44

Profitability (mra)
Return on Invested Capital (ROIC) -1.50
Return on Assets (ROA) -1.12
Return on Equity (ROE) -1.67

Liquidity (mrq)
Quick Ratio 4.15
Current Ratio 4.15

Balance Sheet (mrq) ($M)
Current Assets 15.69
Assets 16.21
Liabilities 7.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G/A Aisling Capital V, LP 3.90 -25.00
02-14 13G/A Leerink Revelation Healthcare Fund I, L.p. 0.00 -100.00
12-13 13G Stonepine Capital Management, LLC 5.40
11-26 13D Sanderling Venture Partners VI LP 18.30
11-14 13G/A Soleus Private Equity Fund III, L.P. 8.50
11-14 13G/A Lytton Laurence W 4.40 -37.99
11-06 13D/A Valence Investments SPV VI, LLC 9.00 4.67

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (AMENDMENT NO. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ T
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 3,010 11,982 25.12
2025-03-10 2,708 7,524 35.99
2025-03-07 6,314 14,058 44.91
2025-03-06 1,184 11,720 10.10

(click for more detail)

Similar Companies
BON – Bon Natural Life Limited BTAI – BioXcel Therapeutics, Inc.
BYSI – BeyondSpring Inc. CAPR – Capricor Therapeutics, Inc.
CARA – Cara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io